These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 29879224)

  • 1. A cell-based infection assay identifies efflux pump modulators that reduce bacterial intracellular load.
    Reens AL; Crooks AL; Su CC; Nagy TA; Reens DL; Podoll JD; Edwards ME; Yu EW; Detweiler CS
    PLoS Pathog; 2018 Jun; 14(6):e1007115. PubMed ID: 29879224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial efflux pump modulators prevent bacterial growth in macrophages and under broth conditions that mimic the host environment.
    Allgood SC; Su C-C; Crooks AL; Meyer CT; Zhou B; Betterton MD; Barbachyn MR; Yu EW; Detweiler CS
    mBio; 2023 Dec; 14(6):e0249223. PubMed ID: 37921493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Multidrug Efflux Inhibitors for Gram-Negative Bacteria.
    Marshall RL; Lloyd GS; Lawler AJ; Element SJ; Kaur J; Ciusa ML; Ricci V; Tschumi A; Kühne H; Alderwick LJ; Piddock LJV
    mBio; 2020 Jul; 11(4):. PubMed ID: 32665275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial Efflux Pump Modulators Prevent Bacterial Growth in Macrophages and Under Broth Conditions that Mimic the Host Environment.
    Allgood SC; Su CC; Crooks AL; Meyer CT; Zhou B; Betterton MD; Barbachyn MR; Yu EW; Detweiler CS
    bioRxiv; 2023 Sep; ():. PubMed ID: 37786697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chlorpromazine and Amitriptyline Are Substrates and Inhibitors of the AcrB Multidrug Efflux Pump.
    Grimsey EM; Fais C; Marshall RL; Ricci V; Ciusa ML; Stone JW; Ivens A; Malloci G; Ruggerone P; Vargiu AV; Piddock LJV
    mBio; 2020 Jun; 11(3):. PubMed ID: 32487753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of Real-Time Assays To Distinguish Multidrug Efflux Pump-Inhibiting and Outer Membrane-Destabilizing Activities in Escherichia coli.
    Misra R; Morrison KD; Cho HJ; Khuu T
    J Bacteriol; 2015 Aug; 197(15):2479-88. PubMed ID: 25962916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loxapine, an antipsychotic drug, suppresses intracellular multiple-antibiotic-resistant Salmonella enterica serovar Typhimurium in macrophages.
    Yang CY; Hsu CY; Fang CS; Shiau CW; Chen CS; Chiu HC
    J Microbiol Immunol Infect; 2019 Aug; 52(4):638-647. PubMed ID: 31239204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Boosting the Antibacterial Activity of Azithromycin on Multidrug-Resistant
    Al-Marzooq F; Ghazawi A; Daoud L; Tariq S
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolomics Reveal Potential Natural Substrates of AcrB in Escherichia coli and Salmonella enterica Serovar Typhimurium.
    Wang-Kan X; Rodríguez-Blanco G; Southam AD; Winder CL; Dunn WB; Ivens A; Piddock LJV
    mBio; 2021 Mar; 12(2):. PubMed ID: 33785633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An efflux pump (MexAB-OprM) of Pseudomonas aeruginosa is associated with antibacterial activity of Epigallocatechin-3-gallate (EGCG).
    Kanagaratnam R; Sheikh R; Alharbi F; Kwon DH
    Phytomedicine; 2017 Dec; 36():194-200. PubMed ID: 29157815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AcrB drug-binding pocket substitution confers clinically relevant resistance and altered substrate specificity.
    Blair JM; Bavro VN; Ricci V; Modi N; Cacciotto P; Kleinekathӧfer U; Ruggerone P; Vargiu AV; Baylay AJ; Smith HE; Brandon Y; Galloway D; Piddock LJ
    Proc Natl Acad Sci U S A; 2015 Mar; 112(11):3511-6. PubMed ID: 25737552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impact of Efflux Pump Inhibitors on the Activity of Selected Non-Antibiotic Medicinal Products against Gram-Negative Bacteria.
    Laudy AE; Kulińska E; Tyski S
    Molecules; 2017 Jan; 22(1):. PubMed ID: 28085074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of different mechanisms to the resistance to fluoroquinolones in clinical isolates of Salmonella enterica.
    Rushdy AA; Mabrouk MI; Abu-Sef FA; Kheiralla ZH; Mohamed Abdel-All S; Saleh NM
    Braz J Infect Dis; 2013; 17(4):431-7. PubMed ID: 23742803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of AcrB Efflux Function Confers Loss of Virulence on
    Wang-Kan X; Blair JMA; Chirullo B; Betts J; La Ragione RM; Ivens A; Ricci V; Opperman TJ; Piddock LJV
    mBio; 2017 Jul; 8(4):. PubMed ID: 28720734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a novel pyranopyridine inhibitor of the AcrAB efflux pump of Escherichia coli.
    Opperman TJ; Kwasny SM; Kim HS; Nguyen ST; Houseweart C; D'Souza S; Walker GC; Peet NP; Nikaido H; Bowlin TL
    Antimicrob Agents Chemother; 2014; 58(2):722-33. PubMed ID: 24247144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of medicinal plants from North Western Himalayas as an efflux pump inhibitor against MDR AcrAB-TolC Salmonella enterica serovar typhimurium: In vitro and In silico studies.
    Mehta J; Rolta R; Dev K
    J Ethnopharmacol; 2022 Jan; 282():114589. PubMed ID: 34492321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-Throughput Flow Cytometry Screening of Multidrug Efflux Systems.
    Haynes MK; Garcia M; Peters R; Waller A; Tedesco P; Ursu O; Bologa CG; Santos RG; Pinilla C; Wu TH; Lovchik JA; Oprea TI; Sklar LA; Tegos GP
    Methods Mol Biol; 2018; 1700():293-318. PubMed ID: 29177837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of natural compound inhibitors for multidrug efflux pumps of Escherichia coli and Pseudomonas aeruginosa using in silico high-throughput virtual screening and in vitro validation.
    Aparna V; Dineshkumar K; Mohanalakshmi N; Velmurugan D; Hopper W
    PLoS One; 2014; 9(7):e101840. PubMed ID: 25025665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efflux Pump Overexpression Contributes to Tigecycline Heteroresistance in
    Chen Y; Hu D; Zhang Q; Liao XP; Liu YH; Sun J
    Front Cell Infect Microbiol; 2017; 7():37. PubMed ID: 28261566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adaptation of clinical isolates of Klebsiella pneumoniae to the combination of niclosamide with the efflux pump inhibitor phenyl-arginine-β-naphthylamide (PaβN): co-resistance to antimicrobials.
    Pacios O; Fernández-García L; Bleriot I; Blasco L; Ambroa A; López M; Ortiz-Cartagena C; González de Aledo M; Fernández-Cuenca F; Oteo-Iglesias J; Pascual Á; Martínez-Martínez L; Tomás M
    J Antimicrob Chemother; 2022 Apr; 77(5):1272-1281. PubMed ID: 35238930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.